drugset / Trial / NCT03991741
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
To determine whether special tumor fighting cells that is taken from participants' tumors and grown in the laboratory and then given back to the participant will fight the participant's cancer when their immune system is suppressed from attacking these special tumor fighting cells.
Timeline
- Start
- 2020-10-07
- Primary completion
- 2023-01-26
- Completion
- 2023-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Tumor Infiltrating Lymphocytes | Cell therapy | — | — |
| Background | aldesleukin | Protein / enzyme biologic | 720000 iu/kg | — |